Bioventus BVS Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bioventus's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bioventus's other accrued liabilities?
- Bioventus (BVS) reported other accrued liabilities of $4.16M in Q1 2026.
- How has Bioventus's other accrued liabilities changed year-over-year?
- Bioventus's other accrued liabilities decreased by 4.6% year-over-year, from $4.36M to $4.16M.
- What is the long-term trend for Bioventus's other accrued liabilities?
- Over 5 years (2020 to 2025), Bioventus's other accrued liabilities has grown at a 1.4% compound annual growth rate (CAGR), from $3.93M to $4.21M.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.